Abstract PO-273: Spatial and descriptive analysis of smoke and vape shop locations focusing on a cancer center neighboring catchment area

INTRODUCTION: Quantitative approaches to the cancer incidence and mortality of a geographic region may lack understanding of the human context in the region thereby affecting how relevant cancer prevention and control activities can best be targeted to a cancer center’s catchment area. OBJECTIVES: The objective of this study was to obtain and analyze qualitative data that described the barriers and facilitators in a cancer center’s catchment area. A further objective was to use the assessment to plan a comprehensive approach to cancer prevention and control activities in the region. METHODS: Extensive qualitative data were gathered from 32 key informants in the 13 county catchment area. We used the Warnecke Model for Analysis of Population Health and Health Disparities to analyze the qualitative data. We coded factors affecting cancer prevention and control using a directed content analysis approach guided by the Warnecke Model. RESULTS: Four outcome types included fundamental barriers such as political environment and discrimination, gaps in resources, and lack of coordinated activities. Social and physical barriers included distrust, diverse language and cultures, and geographic distance. Individual barriers included lack of system negotiation, health literacy, and poverty. Biological barriers were disparate disease rates in specific groups. CONCLUSION: The analysis and assessment led to the creation of a catchment area wide coalition that used the results to formulate a comprehensive strategic plan to address the barriers in the region.

Download Full-text

Increasing Mean Age of Head and Neck Cancer Patients at a German Tertiary Referral Center

Cancers ◽

10.3390/cancers13040832 ◽

2021 ◽

Vol 13 (4) ◽

pp. 832

Author(s):

Julius M. Vahl ◽

Marlene C. Wigand ◽

Michael Denkinger ◽

Dhayana Dallmeier ◽

Chiara Steiger ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Catchment Area ◽

Incidence Rates ◽

Cancer Center ◽

Tertiary Referral ◽

Tertiary Referral Center ◽

Referral Center ◽

The Impact

Background: The impact of demographic change on the age at diagnosis in German head and neck cancer (HNC) patients is unclear. Here we present an evaluation of aging trends in HNC at a tertiary referral center. Methods: Retrospective cohort study on aging trends at the initial diagnosis of newly diagnosed patients with HNC between 2004 and 2018 at the head and neck cancer center Ulm in relation to demographic data of the catchment area. Results: The study population consisted of 2450 individuals diagnosed with HNC with a mean age of 62.84 (±11.67) years. We observed a significant increase in annual incidence rates and mean age over time. Mean age among HNC patients increased significantly more than among the population in the catchment area. Whereas the incidence rate of patients <50 years did not change, the incidence of HNC patients aged ≥70 years increased the most. The mean patient age in the main tumor sites increased significantly. Surprisingly, HPV-positive patients were not younger than HPV-negative patients, but showed a non-significant trend towards a higher mean age (63.0 vs. 60.7 years). Conclusions: Increasing incidence rates in older patients pose a challenge for health care systems. A nationwide study is needed to assess the dynamics and impact of aging on the incidence of HNC.

Download Full-text

OPTIK: a database for understanding catchment areas to guide mobilization of cancer center assets

Database ◽

10.1093/database/baaa054 ◽

2020 ◽

Vol 2020 ◽

Author(s):

Dinesh Pal Mudaranthakam ◽

Lisa M Harlan-Williams ◽

Roy A Jensen ◽

Hanluen Kuo ◽

Vandita Garimella ◽

...

Keyword(s):

Data Warehouse ◽

Catchment Area ◽

Data Sources ◽

Cancer Center ◽

Common Denominator ◽

Patient Privacy ◽

Research Activities ◽

Incidence And Mortality ◽

Catchment Areas ◽

The Impact

Abstract An increasingly diversified demographic landscape in rural and urban America warrants the attention of The University of Kansas Cancer Center (KU Cancer Center) researchers, clinicians, outreach staff and administrators as the institution assesses ways to reach its expansive, bi-state catchment area. Within the counties of the KU Cancer Center catchment area, patient level and public health data are available and categorized by varying geographic regional boundaries. Multiple data sources and different data collection processes complicate summarizing catchment area data. A curated data warehouse that retrieves and structures the data, with a common denominator, can support meaningful use of the data in a standard and consistent format. The KU Cancer Center built a data warehouse to Organize and Prioritize Trends to Inform KU Cancer Center (OPTIK), which functions to streamline the process of synthesizing data regarding Kansas and Missouri demographics, cancer risk factors and incidence and mortality rates. OPTIK standardizes these diverse data sources to enable analyses of the cancer burden at local, regional and national levels while upholding a strict standard of patient privacy. The OPTIK database enables researchers to use available data and create heat maps and other visualizations to aid in funding proposals, presentations and research activities. Furthermore, using knowledge provided by OPTIK, the KU Cancer Center is able to prioritize action items for research and outreach and more effectively communicate the impact of those efforts.

Download Full-text

Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic?

Journal of Oncology Pharmacy Practice ◽

10.1177/1078155210389216 ◽

2011 ◽

Vol 17 (4) ◽

pp. 425-432 ◽

Cited By ~ 30

Author(s):

Aimee Danette Ruder ◽

Douglas Lamont Smith ◽

Michael Thornton Madsen ◽

Frederic Henry Kass

Keyword(s):

Patient Education ◽

Clinical Oncology ◽

Medication Reconciliation ◽

Drug Information ◽

Descriptive Analysis ◽

Cost Savings ◽

Cancer Center ◽

Control Cost ◽

Clinical Interventions ◽

Ambulatory Oncology

Background. The John Marsh Cancer Center is an ambulatory oncology clinic located in Hagerstown, MD. In 2004, a clinical oncology pharmacist was hired to help manage therapies and control cost. The objective was to evaluate clinical interventions, consultations and cost savings by the clinical oncology pharmacist. Methods. This was a retrospective descriptive analysis of clinical interventions by the clinical oncology pharmacist from September 4, 2004 to October 27, 2006. Interventions were categorized as either drug-related or consultative. Drug-related interventions included medication reconciliation, dosing, and adverse effect management and prevention. Consultations incorporated drug information questions, patient visits, and patient education sessions. Information was extracted from an online documentation program linked to medical charts. Results. A total of 583 clinical interventions were documented among 199 patients. Average time spent per intervention was 10 minutes. Drug-related and consultative interventions accounted for 35% and 65%, respectively. Included among the drug-related interventions were adverse events (131), medication reconciliation (52) and dosing (22). Consultation services consisted of patient education (143), patient visits (124) and drug information (25). The on-site pharmacist saved $210,000 by admixing chemotherapy. Patient and colleague surveys evaluated pharmacist services with positive ratings of 95% and 98%, respectively. Conclusion. Analysis of clinical interventions, cost-savings, and feedback from patients and colleagues confirmed beneficial services provided by a clinical pharmacist in this outpatient oncology center.

Download Full-text

Port-a-Cath fracture and migration in paediatric cancer patients: incidence and management at a tertiary care centre – a 15-year experience

Cardiology in the Young ◽

10.1017/s1047951120001390 ◽

2020 ◽

Vol 30 (7) ◽

pp. 986-990

Author(s):

Amr Elgehiny ◽

Khaled Ghanem ◽

Haytham Bou Hussein ◽

Mohamed Ahmed ◽

Mostafa Abohelwa ◽

...

Keyword(s):

Cancer Patients ◽

Rare Complication ◽

Central Venous Access ◽

Descriptive Analysis ◽

Tertiary Care ◽

Cancer Center ◽

Paediatric Cancer ◽

Tertiary Care Centre ◽

First Choice ◽

And Migration

AbstractIntroduction:Port-a-Cath or chemoport provides prolonged central venous access for cancer patients requiring prolonged chemotherapy. Prolonged use of chemoport is associated with many complications. Dislodgement and migration of chemoport catheter is a rare and reportable complication with potentially serious consequences.Methods:The medical charts of 1222 paediatric cancer patients admitted to the Children’s Cancer Center in Lebanon who had chemoports inserted for long-term chemotherapy were retrospectively reviewed. Descriptive analysis of data was conducted.Results:Chemoport fracture and migration were found in seven cases with an incidence of 0.57%. The duration of chemoport use before the event of dislodgement varied from 2 months to 102 months. Non-functioning chemoport was the most common presentation. Totally, six cases were managed successfully by loop snaring, three cases by paediatric cardiology team, and three cases by interventional radiology team. One case was managed surgically during chemoport removal.Conclusion:Fracture and migration of chemoport catheter is a rare complication of uncertain aetiology and with potentially serious consequences. Percutaneous retrieval, done by experienced cardiologist or interventional radiologist, is the first choice for management of this complication as it is considered as a safe and effective approach.

Download Full-text

Impact of a mass media campaign (MMC) on awareness of and willingness to participate in cancer clinical trials (CCT): Results from 2,269 survey respondents

Journal of Clinical Oncology ◽

10.1200/jco.2006.24.18_suppl.6012 ◽

2006 ◽

Vol 24 (18_suppl) ◽

pp. 6012-6012

Author(s):

A. Umutyan ◽

P. N. Lara ◽

C. Chiechi ◽

C. Turrell ◽

M. S. Chen ◽

...

Keyword(s):

Catchment Area ◽

Demographic Variables ◽

Third Party ◽

Cancer Center ◽

Control Group ◽

Cancer Clinical Trials ◽

Media Campaign ◽

Willingness To Participate ◽

Education Groups ◽

Care Costs

6012 Background: Annually, only 3% of patients (pt) participate in CCT. Accrual barriers include lack of CCT awareness and uncertain third party coverage. In 1/02, a California law (SB37) required all third party payers to reimburse pt care costs related to CCT. We sought to increase awareness of CCT/SB37 through a MMC, and assessed willingness to participate. Methods: Following a pre-MMC survey of 1,188 cancer pt and/or their caregivers’ awareness and willingness levels (JCO 2005; 23:9282–89), a TV/radio/print/internet MMC was conducted in a 9-county catchment area for UC Davis Cancer Center from 4/05–6/05. The MMC emphasized CCT/SB37 availability and used an iconic “Big C” logo. The survey was repeated post-MMC in two pt/caregiver cohorts: from the UC Davis Cancer Center catchment area (C1), and a control group from the UC San Diego area (C2) who did not see the MMC. Changes in CCT/SB37 awareness and willingness to participate were probed pre- vs. post-MMC and C1 vs. C2 by Pearson χ2 & logistic regression. Results: Of 2,269 respondents, 1,081 were post-MMC: 957 from C1 and 124 from C2. Post-MMC respondents differed from pre-MMC by respondent type (pt > caregivers), age (older), race (more blacks), and income (more $75k+/yr). Pre- vs. post-MMC, C1 respondents had greater awareness of CCT (59% to 65%, p < 0.01) and SB37 (17% vs. 32%, p < 0.01); no significant change was seen in C2. Adjustment for demographic variables in C1 resulted in p > 0.05 for CCT/SB37 awareness. Willingness to participate in CCT did not change pre- vs. post-MMC in C1 or C2. Awareness level predicted willingness (OR = 2.3, p < 0.01), but this was not true for the lowest income/education groups. Blacks/Asians/lowest income (< $25K/yr) groups were least willing to participate (p < 0.01/0.04/0.02). Conclusions: Although CCT/SB37 awareness increased in C1 following the MMC, it is unclear whether this was wholly attributable to the MMC due to varying demographic variables. Awareness of CCT/SB37 did not universally translate into willingness to participate in all subgroups. Enhancing pt willingness (to increase CCT accrual) will require targeting other variables, such as physician or resource barriers, rather than just CCT/SB37 awareness. (R21 CA-03501). No significant financial relationships to disclose.

Download Full-text

Integrating contemplative and spiritual care in outpatient palliative care: A pilot study.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.26_suppl.247 ◽

2016 ◽

Vol 34 (26_suppl) ◽

pp. 247-247

Author(s):

Craig D Blinderman ◽

Alex Beth Schapiro

Keyword(s):

Palliative Care ◽

Spiritual Care ◽

Descriptive Analysis ◽

Care Program ◽

Well Being ◽

Comprehensive Cancer Center ◽

Cancer Center ◽

Pilot Program ◽

Palliative Care Program ◽

Care Clinic

247 Background: Spiritual support is associated with better outcomes in cancer care and at the end of life (1, 2). Consensus guidelines advocate for incorporating spiritual care in the provision of specialist level palliative care (3). Contemplative care practices and chaplaincy interventions have the potential for mitigating existential distress, cultivating prognostic awareness, and fostering spiritual approaches to grieving and coping with advanced cancer. We present the results of a pilot program demonstrating the feasibility and impact of integrating a contemplative care chaplain in an outpatient palliative care program in a culturally diverse patient population in a large, academic cancer center. Methods: Case series and descriptive analysis. A description of 10 cases seen by a contemplative care chaplain in our outpatient palliative care clinic in the Herbert Irving Comprehensive Cancer Center (HICCC) at Columbia University will be presented. A descriptive analysis using a chaplaincy-centered model of assessment will highlight the domains of suffering and subjective integration of psychosocial and spiritual concepts. Results: Patients were generally in favor of meeting with and sharing their feelings openly with the chaplain. Patients’ describe important domains pertinent to their well being: meaning, family integration, spiritual practices, existential concerns, prognostic awareness. Subjective transformation and integration of the following constructs: “healing,” “gratitude,” “anger,” “hope,” “fear” were possible with only a few patient encounters. None of the patients were opposed to an initial visit and assessment. In only one case, the family requested not having further visits due to strong emotional reactions that came up. Conclusions: Preliminary results from a novel, pilot program integrating contemplative and spiritual care in an outpatient palliative care program suggest that it is a feasible intervention and should be considered in other cancer centers. Further studies will need to qualify and quantify the additional value and impact of spiritual care integrated in ambulatory palliative care services.

Download Full-text

Accrual of Black participants to cancer clinical trials following a five-year prospective initiative of community outreach and engagement.

Journal of Clinical Oncology ◽

10.1200/jco.2021.39.15_suppl.100 ◽

2021 ◽

Vol 39 (15_suppl) ◽

pp. 100-100

Author(s):

Carmen E. Guerra ◽

Vicki Sallee ◽

Wei-Ting Hwang ◽

Brenda Bryant ◽

Armenta L. Washington ◽

...

Keyword(s):

Clinical Trial ◽

Clinical Trials ◽

Catchment Area ◽

Community Outreach ◽

Fold Increase ◽

Cancer Center ◽

Black Communities ◽

Cancer Clinical Trials ◽

Black Patients ◽

Clinical Trial Accrual

100 Background: Accrual of Black participants to cancer clinical trials remains a major challenge across the country. Here, we report the outcomes of a five-year initiative of community outreach and engagement to improve enrollment of adult Black participants to clinical trials at the Abramson Cancer Center (ACC) at the University of Pennsylvania. Methods: Primary metrics were the percentage of Black patients among all cancer cases in our catchment area, the percentage of adult Black patients cared for at the ACC, and the percentage of adult Black participants enrolled on the three types of NCI-defined clinical trials. Results: In 2014, at baseline, Black residents comprised 19% of the population and 16.5% of cancer cases in our catchment area surrounding Philadelphia, but only 11.1% of ACC patients were Black. The percentages of Black participants accrued onto treatment, non-therapeutic interventional, and non-interventional trials were 12.2%, 8.3%, and 13.0%, respectively. We then established a center-wide program with community guidance to address these gaps. Key elements of the program included: 1) culturally tailored marketing strategies for cancer clinical trials; 2) plans for each protocol to facilitate Black participant enrollment; 3) new partnerships with faith-based organizations serving Black communities to conduct educational events about clinical trials; 4) pilot programs with Lyft and Ride Health to address transportation barriers; 5) patient education by nurse navigators regarding cancer and clinical trials; and 6) an improved informed consent process. These efforts reached more than 10,000 individuals in venues including churches, neighborhoods, community parks and centers, and health centers with formats ranging from educational forums to wellness fairs. Reassessing metrics in 2018, we found that the percentage of Black patients seen at ACC had increased to 16.2%, matching the percentage of Black cancer patients among all cancer cases in our catchment area (16.5%). Total cancer clinical trial accrual had increased from 9,308 participants in 2014 to 13,170 in 2018 (41.5% increase). The percentages of Black participants accrued onto treatment, non-therapeutic interventional, and non-interventional trials were 23.9%, 33.1%, and 22.5%, respectively – a 1.7- to 4.0-fold increase in five years and higher than the percentage of Black patients seen at the ACC. Conclusions: Our multifaceted, community-based engagement initiative to encourage clinical trial enrollment was associated with improved accrual of Black participants to cancer clinical trials. These findings also suggest that gaps in access to cancer centers are a key factor driving access to clinical trials. Medicaid expansion occurred concurrently in all states in our catchment area and its impact on accrual merits further research.

Download Full-text